Etofibrate

Etofibrate

SCHEMBL8168409

CC(C)(Oc1ccc(Cl)cc1)C(=O)OCCOC(=O)c1cccnc1.CC(C)(Oc1ccc(Cl)cc1)C(=O)OCCOC(=O)c1cccnc1

nearest known ligand 0.55

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.55
KMT2A Q03164 6/20 0.55
LMNA P02545 5/20 0.55
ALDH1A1 P00352 4/20 0.55
MEN1 O00255 2/20 0.55
USP2 O75604 1/20 0.55
CYP1A2 P05177 3/20 0.54
CYP3A4 P08684 2/20 0.54
TSHR P16473 2/20 0.54
ABCB11 O95342 1/20 0.54
HTR2A P28223 1/20 0.54
PMP22 Q01453 1/20 0.54
PPARA Q07869 1/20 0.54
CYP2C9 P11712 2/20 0.54
CYP2C19 P33261 2/20 0.54
SMN1; SMN2 Q16637 1/20 0.52
MAPT P10636 2/20 0.48
HPGD P15428 1/20 0.48
KDM4E B2RXH2 1/20 0.47
THRB P10828 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Etofibrate SCHEMBL3122 1.00 L3MBTL1 (0.55) L3MBTL1KMT2ALMNAALDH1A1MEN1
Etofibrate SCHEMBL29801484 1.00 L3MBTL1 (0.55) L3MBTL1KMT2ALMNAALDH1A1MEN1
Etofibrate SCHEMBL1649349 0.99 L3MBTL1 (0.54) L3MBTL1KMT2ALMNAALDH1A1MEN1
Ronifibrate SCHEMBL48852 0.96 L3MBTL1 (0.59) L3MBTL1KMT2ALMNAALDH1A1MEN1
Simfibrate SCHEMBL5808862 0.96 L3MBTL1 (0.59) L3MBTL1KMT2ALMNAALDH1A1MEN1
SCHEMBL10973734 0.92 L3MBTL1 (0.55) L3MBTL1KMT2ALMNAALDH1A1MEN1
Picafibrate SCHEMBL2109083 0.85 SMN1; SMN2 (0.65) KMT2ALMNAALDH1A1MEN1USP2
Binifibrate SCHEMBL49116 0.85 KMT2A (0.51) L3MBTL1KMT2ALMNAALDH1A1MEN1
Binifibrate SCHEMBL29388376 0.85 KMT2A (0.51) L3MBTL1KMT2ALMNAALDH1A1MEN1
SCHEMBL2615470 0.84 L3MBTL1 (0.59) L3MBTL1KMT2ALMNAALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2000069446-A1 COMBINATION THERAPY FOR TREATING HYPERCHOLESTEROLEMIA GELTEX PHARMACEUTICALS, INC. (US) 2000-11-23 WO disclosed
EP-0971744-A2 COMBINATION THERAPY EMPLOYING ILEAL BILE ACID TRANSPORT INHIBITING BENZOTHIEPINES AND HMG Co-A REDUCTASE INHIBITORS G.D. SEARLE & CO. (US) 2000-01-19 EP disclosed
WO-1998040375-A2 COMBINATION OF ILEAL BILE ACID TRANSPORT INHIBITING BENZOTHIEPINES AND HMG Co-A REDUCTASE INHIBITORS G.D. SEARLE & CO. (US) 1998-09-17 WO disclosed